BJA Advance Access published online on April 4, 2006
British Journal of Anaesthesia, doi:10.1093/bja/ael082
1 Department of Anesthesiology and Intensive Care, University of Rome ‘La Sapienza’, Rome, Italy
* To whom correspondence should be addressed. Background. The calcium sensitizer levosimendan protects against myocardial ischaemia and reperfusion injury in animal models. Methods. The present pilot study investigated whether a short infusion before coronary artery bypass grafting (CABG) would protect the myocardium and improve postoperative haemodynamics. Twenty-four patients with stable angina undergoing elective CABG surgery were randomized to receive either placebo or levosimendan (24 µg kg-1) infused i.v. over a 10 min period just before placing the patient on cardiopulmonary bypass. Results. Perioperative haemodynamic variables, concentrations of cardiac troponin I over the 48 h postoperative period, and clinical outcomes were assessed. There were no adverse effects related to levosimendan. Compared with control patients, levosimendan-treated patients had lower postoperative troponin I concentrations (P<0.05) and a higher cardiac index (P<0.05). Conclusion. Patients receiving a short infusion of levosimendan before CABG showed evidence of less myocardial damage, suggestive of a preconditioning effect. Larger outcome studies are thus indicated to confirm benefit.
Accepted March 7, 2006
Clinical Investigation
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study
L. Tritapepe 1,
V. De Santis 1 *,
D. Vitale 1,
M. Santulli 2,
A. Morelli 1,
I. Nofroni 3,
P. E. Puddu 4,
M. Singer 5
,
and
P. Pietropaoli 1
2 Department of Cellular Biotechnology and Haematology, University of Rome ‘La Sapienza’, Rome, Italy
3 Department of Experimental Medicine and Pathology, University of Rome ‘La Sapienza’, Rome, Italy
4 VOC di Biotecnologie Applicate alle Malattie Cardiovasculari, Department of the Heart and Great Vessels ‘Attilio Reale’, University of Rome ‘La Sapienza’, Rome, Italy
5 Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK
V. De Santis, E-mail: vincenzo.desantis{at}uniroma1.it
![]()
Abstract
Declaration of interest. M.S. has sat on advisory boards for levosimendan on behalf of Orion, the manufacturer, and Abbott, the distributor. He has also received honoraria for chairing/speaking at satellite symposia and for co-editing a website, failinghears.com, supported by an unrestricted educational grant from Abbott.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Mongardon, A. Dyson, and M. Singer Pharmacological optimization of tissue perfusion Br. J. Anaesth., July 1, 2009; 103(1): 82 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Venugopal, A. Ludman, D. M. Yellon, and D. J. Hausenloy 'Conditioning' the heart during surgery Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 977 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Eriksson, J. R. Jalonen, L. O. Heikkinen, M. Kivikko, M. Laine, K. A. Leino, A. H. Kuitunen, K. T. Kuttila, T. K. Perakyla, T. Sarapohja, et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann. Thorac. Surg., February 1, 2009; 87(2): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tritapepe, V. De Santis, D. Vitale, F. Guarracino, F. Pellegrini, P. Pietropaoli, and M. Singer Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery Br. J. Anaesth., February 1, 2009; 102(2): 198 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Pagel Levosimendan in Cardiac Surgery: A Unique Drug for the Treatment of Perioperative Left Ventricular Dysfunction or Just Another Inodilator Searching for a Clinical Application? Anesth. Analg., April 1, 2007; 104(4): 759 - 761. [Full Text] [PDF] |
||||
![]() |
S. G. De Hert, S. Lorsomradee, S. Cromheecke, and P. J. Van der Linden The Effects of Levosimendan in Cardiac Surgery Patients with Poor Left Ventricular Function Anesth. Analg., April 1, 2007; 104(4): 766 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, A. Kumar, and V. De Santis The preconditioning effects of levosimendan. Br. J. Anaesth., September 1, 2006; 97(3): 425 - 425. [Full Text] [PDF] |
||||
E-letters:
Read all E-letters
- MIP: Many questions unanswered.
- Dr Sumit Kumar Jha, et al.
- British Journal of Anaesthesia, 18 May 2006 [Full text]
- Re: MIP: Many questions unanswered.
- Vincenzo De Santis
- British Journal of Anaesthesia, 31 May 2006 [Full text]



